Supplements

Phosphatidylserine

Evidence: strong_human

Mechanism of Action

Major phospholipid component of neuronal cell membranes (15-20% of total phospholipid pool) that maintains membrane fluidity and supports signal transduction. Serves as a cofactor for protein kinase C (PKC), Na+/K+-ATPase, and other membrane-bound enzymes critical for neurotransmitter release. Blunts HPA axis hyperactivation by modulating corticotrophin-releasing factor (CRF) receptor interactions, attenuating cortisol release during physical and psychological stress. Facilitates acetylcholine, dopamine, and norepinephrine release, and enhances glucose metabolism in the brain.

Dosing Protocol

Standard: 100-300mg daily

Loading: 300 mg/day for first 30 days

Maintenance: 100-200 mg/day

Administration: oral

Timing: With meals (fat-containing preferred for absorption). Can be taken morning or evening. Cortisol-blunting effects are relevant for evening/pre-bed dosing in stressed individuals.

Duration: Ongoing; no cycling required. Clinical benefits observed from 6-12 weeks.

Notes

The FDA allows a qualified health claim for PS and cognitive dysfunction/dementia, though with the caveat that evidence is limited. The Crook 1991 trial (149 subjects, 300mg BC-PS) is the landmark study showing memory improvement in age-associated memory impairment. The cortisol-blunting effect (demonstrated at 600-800mg) makes PS particularly useful for chronically stressed individuals. DHA-conjugated PS (PS-DHA) may offer superior brain uptake. The switch from bovine to soy-derived PS is a legitimate concern — most positive trials used bovine-derived material. One of the safest nootropics available with an excellent side-effect profile.

Stacking

  • Omega-3 (DHA)
  • Acetyl-L-Carnitine
  • Alpha-GPC
  • Ginkgo Biloba
  • Bacopa Monnieri
  • Piracetam

Interactions

  • Anticholinergic drugs [MEDIUM] — PS increases cholinergic activity — may oppose anticholinergic medications
  • Blood thinners [LOW] — Theoretical mild anticoagulant effect
  • Anticholinergic drugs [LOW] — May partially counteract PS-mediated cholinergic enhancement
  • Cholinesterase inhibitors [LOW] — Theoretical additive cholinergic effects
  • Anticoagulants [LOW] — High-dose PS may have mild anticoagulant properties

Contraindications

  • Soy allergy (if soy-derived — use sunflower-derived instead)
  • Known soy allergy (soy-derived PS)
  • Antiphospholipid syndrome (theoretical concern)

Side Effects

  • Mild GI upset at high doses
  • Insomnia (if taken too late in some individuals)
  • Rare: nausea
  • GI distress (uncommon)
  • Insomnia (at higher doses)
  • Headache (rare)

Key Papers

  • 10.1016/j.nutres.2014.11.009
  • 10.1007/s00421-007-0614-4
  • 10.1016/j.pnpbp.2014.01.010
  • 10.1212/WNL.41.5.644
  • 10.1016/j.nut.2014.10.014
  • 10.1186/1550-2783-5-11

Source Quality

Originally derived from bovine cortex (BC-PS) — most clinical trials used this source, but it has been discontinued due to BSE/prion concerns. Modern PS is soy-derived or sunflower-derived. Soy-derived PS has some clinical validation but may not be equivalent to BC-PS. Sunflower-derived PS avoids soy allergen concerns. Sharp-PS (Enzymotec/Frutarom) is a well-validated branded form. Look for >50% phosphatidylserine content by HPLC.

Disclaimer: This information is for educational purposes only and is not medical advice. BioAccelera Labs does not diagnose, treat, or prescribe. Consult a licensed healthcare provider before using any compound.

Should Phosphatidylserine Be in Your Stack?

Take the free assessment and get personalized recommendations based on your biology and goals.

Get Your Free Protocolor take the assessment →
← Browse All 231 Compounds